Fig. 6: Change in CGI-S score distribution from baseline at week 5a. | Schizophrenia

Fig. 6: Change in CGI-S score distribution from baseline at week 5a.

From: Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials

Fig. 6

A CGI-S score distribution at baseline. B CGI-S score distribution at week 5. aCGI-S scores were available at week 5 for 244 participants in the xanomeline/trospium group and 263 participants in the placebo group. CGI-S Clinical Global Impression–Severity, X/T xanomeline/trospium.

Back to article page